Hello, we’re Countable Labs.
We’re here to solve your biggest problems in DNA quantification.
We believe the future of PCR is Countable. Quantification in genomics should finally live up to its promise.
We knew that the most essential part of genomics — quantification — has been stuck in tools like qPCR, digital PCR, and NGS that require too many tradeoffs to reach true accuracy.
From estimation and multiplexing challenges to workflow complexity and overhead, precision has always come at a price.
We built Countable PCR to change that. No more compromises. No more estimation. Just true target counts, at single-molecule resolution, with a straightforward workflow — finally making quantification as direct, reliable, and accessible as it should be.
We want to make diagnostics more accessible and enable the future of precision genomics.
We build genomics tools that push the boundaries of what’s possible because our ultimate goal is for patients to get easier access to clear insights about their health, especially when early detection changes lives.
This requires solutions that are more sensitive, more affordable, and less complicated.
That’s why we focus on developing technology that removes barriers for scientists doing the work — so they move faster and more confidently with everyday decisions in biomarker analysis, gene therapeutics, and clinical diagnostics.
We’ve built tools that have changed the genomics landscape several times.
We’re a group of seasoned life science entrepreneurs, engineers, and scientists with a proven track record of redefining what’s possible in genomics, developing solutions from idea to commercial success, and building lasting brands.
Our founding team pioneered DNA microarrays, non-invasive prenatal screening, high-throughput single-cell NGS, and spatial genomics — and, together, holds over 60 granted patents.
We’re backed by the best in the business.

Ari Chaney
Co-Founder & Board Director, 13.8

Stephen Fodor
Co-Founder & Board Director, 13.8

Dara Wright
Board Director, Independent

Jocelyn Davé
CEO & Board Director, Countable Labs
We’re enabling new capabilities.
We're now Countable Labs but some publications use our former name Enumerix.
Also, our technology is Countable PCR, formerly UltraPCR.
"Using a 4-color optical setup, we demonstrate that we can incorporate 10 different fluorescent dyes in the same [reaction]"
Janice H. Lai, et al. 2023.
"Single template separation ... can aid high-order multiplexing assay designs to achieve NGS-like precision DNA counting"
Eleen Y. Shum, et al. 2022
“This approach exhibits improved accuracy over existing dPCR platforms and enables a greatly increased dynamic range…”
Peiyu Liao, et al. 2020

